A fast, high-signal review designed to help investors identify early clinical, ethical, and regulatory red flags before committing deeper diligence or capital. We assess whether a product can realistically function within healthcare, mental health, or wellness systems and where hidden human or liability risks may emerge. Ideal for early screening, deal triage, and informed IC discussions.

A comprehensive, systems-level diligence process for high-conviction or higher-risk investments. We examine how a product interacts with real clinical workflows, human behavior, regulatory obligations, and ethical expectations, surfacing downstream risks that traditional diligence often misses. Designed to inform valuation, timing, and long-term defensibility.

An ongoing advisory partnership that embeds clinical and systems-level risk intelligence into your investment process. We support deal flow evaluation, portfolio company risk management, and regulatory horizon scanning across your fund. Ideal for investors with repeated exposure to healthcare, mental health, or AI-enabled products.

• Founder Risk Readiness Session
  Prepare founders to address clinical, ethical, and regulatory risk in IC or board discussions

• Regulatory Scenario Mapping
  Evaluate how changes in law, enforcement, or standards could affect product viability or exit timelines

• Post-Investment Risk Remediation Plan
  Translate identified risks into structured, actionable mitigation steps

• IC or LP Briefings
  Plain-language explanations of complex risk for non-clinical stakeholders

• Thematic Risk Reviews
  Cross-portfolio analysis of recurring risks (e.g., AI in mental health, consumer wellness claims, data use)